Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantation-Reference-Cited by-同舟云学术

Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantation

Published:2011-09-16 Issue:9 Volume:118 Page:2411-2419
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Fang Min,Storer Barry,Wood Brent,Gyurkocza Boglarka,Sandmaier Brenda M.,Appelbaum Frederick R.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference21 articles.

1. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study;Slovak;Blood,2000

2. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties;Grimwade;Blood,1998

3. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet;Dohner;Blood,2010

4. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461);Byrd;Blood,2002

5. Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from Cancer and Leukemia Group B Study 8461;Marcucci;J Clin Oncol,2004

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Measurable (Minimal) Residual Disease in Myelodysplastic Neoplasms (MDS): Current State and Perspectives;Cancers;2024-04-15

2. Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML;American Journal of Hematology;2024-02-21

3. Prognostic value of combined WT1 and multiparameter flow cytometry assessment for measurable residual disease after induction in non-APL acute myeloid leukemia;Scandinavian Journal of Clinical and Laboratory Investigation;2023-06-24

4. Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia;Haematologica;2022-08-04

5. Targeting an alternate Wilms’ tumor antigen 1 peptide bypasses immunoproteasome dependency;Science Translational Medicine;2022-02-09